164 related articles for article (PubMed ID: 25420468)
21. Psoralen-ultraviolet A therapy vs. psoralen-ultraviolet B therapy in the treatment of plaque-type psoriasis: our experience with fitzpatrick skin type IV.
Khurshid K; Haroon TS; Hussain I; Pal SS; Jahangir M; Zaman T
Int J Dermatol; 2000 Nov; 39(11):865-7. PubMed ID: 11123453
[TBL] [Abstract][Full Text] [Related]
22. Photo(chemo)therapy for vitiligo.
Pacifico A; Leone G
Photodermatol Photoimmunol Photomed; 2011 Oct; 27(5):261-77. PubMed ID: 21950634
[TBL] [Abstract][Full Text] [Related]
23. Treatment of psoriasis with polyethylene sheet bath PUVA.
Streit V; Wiedow O; Christophers E
J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):208-10. PubMed ID: 8708022
[TBL] [Abstract][Full Text] [Related]
24. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
25. Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing.
Feldman SR; Nijsten T; Margolis DJ; Rolstad T
J Am Acad Dermatol; 2005 Jan; 52(1):140-1. PubMed ID: 15627096
[No Abstract] [Full Text] [Related]
26. Psoralen ultraviolet A therapy in 2004.
Morison WL
Photodermatol Photoimmunol Photomed; 2004 Dec; 20(6):315-20. PubMed ID: 15533240
[No Abstract] [Full Text] [Related]
27. Bath-PUVA therapy decreases infiltrating CCR4-expressing tumor cells and regulatory T cells in patients with mycosis Fungoides.
Kato H; Saito C; Ito E; Furuhashi T; Nishida E; Ishida T; Ueda R; Inagaki H; Morita A
Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):273-80. PubMed ID: 23332394
[TBL] [Abstract][Full Text] [Related]
28. Treatment of palmoplantar psoriasis with monochromatic excimer light (308-nm) versus cream PUVA.
Neumann NJ; Mahnke N; Korpusik D; Stege H; Ruzicka T
Acta Derm Venereol; 2006; 86(1):22-4. PubMed ID: 16585984
[TBL] [Abstract][Full Text] [Related]
29. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
[TBL] [Abstract][Full Text] [Related]
30. [Photochemotherapy of psoriasis using a Soviet-made furocoumarin preparation psorberan].
Kapkaev RA; Liuban BL; Akovbian VA
Vestn Dermatol Venerol; 1983 Dec; (12):48-50. PubMed ID: 6369824
[No Abstract] [Full Text] [Related]
31. Psoralen photochemotherapy.
McClelland PB; Morgan P; Leach EE; Shelk J
Dermatol Nurs; 1997 Dec; 9(6):403-15; quiz 416-7. PubMed ID: 9460332
[TBL] [Abstract][Full Text] [Related]
32. [Clinical and histological evaluation of oral psoralen plus UV-A exposure (PUVA) for treating psoriasis vulgaris (author's transl)].
Jimbow K; Nishio C; Uesugi T; Katoh M; Kato M; Makita A; Chiba M; Horikoshi T
Nihon Hifuka Gakkai Zasshi; 1978; 88(1):23-36. PubMed ID: 306462
[No Abstract] [Full Text] [Related]
33. Bath PUVA and psoriasis: is a milder treatment a worse treatment?
Delrosso G; Bornacina C; Farinelli P; Bellinzona F; Leigheb G; Colombo E
Dermatology; 2008; 216(3):191-3. PubMed ID: 18182808
[TBL] [Abstract][Full Text] [Related]
34. Topical psoralen-ultraviolet A therapy for palmoplantar dermatoses: experience with 35 consecutive patients.
Davis MD; McEvoy MT; el-Azhary RA
Mayo Clin Proc; 1998 May; 73(5):407-11. PubMed ID: 9581579
[TBL] [Abstract][Full Text] [Related]
35. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
[TBL] [Abstract][Full Text] [Related]
36. Randomized double-blind comparative study of 8-methoxypsoralen bath plus UV-A treatment regimens.
Berroeta L; Man I; Dawe RS; Ferguson J; Ibbotson SH
Actas Dermosifiliogr; 2010 Oct; 101(8):729-30. PubMed ID: 20965019
[No Abstract] [Full Text] [Related]
37. The contribution of medical physics to the development of psoralen photochemotherapy (PUVA) in the UK: a personal reminiscence.
Diffey B
Phys Med Biol; 2006 Jul; 51(13):R229-44. PubMed ID: 16790905
[TBL] [Abstract][Full Text] [Related]
38. High-dose prednisolone and psoralen ultraviolet A combination therapy in 36 patients with vitiligo.
Lee Y; Seo YJ; Lee JH; Park JK
Clin Exp Dermatol; 2007 Sep; 32(5):499-501. PubMed ID: 17608760
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of different treatment frequencies of psoralen and ultraviolet A in psoriatic patients with darker skin types (randomized-controlled study).
El-Mofty M; El Weshahy H; Youssef R; Abdel-Halim M; Mashaly H; El Hawary M
Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):38-42. PubMed ID: 18201356
[TBL] [Abstract][Full Text] [Related]
40. Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma.
McGinnis KS; Shapiro M; Vittorio CC; Rook AH; Junkins-Hopkins JM
Arch Dermatol; 2003 Jun; 139(6):771-5. PubMed ID: 12810509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
